NCT03762915View on ClinicalTrials.gov

Scaling and Root Planing (SRP) With and Without Minocycline HCl Microspheres, 1 mg

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

May 20, 2019

Primary Completion Date

April 1, 2022

Study Completion Date

April 1, 2022

Conditions
SRPMinocycline HCl MicrospheresBiomarkers
Interventions
DRUG

minocycline HCl microspheres

Minocycline HCl microspheres, 1 mg are approved by the Food and Drug Administration (FDA) as an adjunct to SRP procedures for reduction of pocket depth in patients with adult periodontitis.

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
collaborator

Bausch Health Americas, Inc.

INDUSTRY

lead

University of Minnesota

OTHER

NCT03762915 - Scaling and Root Planing (SRP) With and Without Minocycline HCl Microspheres, 1 mg | Biotech Hunter | Biotech Hunter